Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
18.28 USD | +1.67% | -1.30% | -4.60% |
Mar. 20 | Myriad Genetics Gets US Patent for SneakPeek Snap Device | MT |
Feb. 27 | Transcript : Myriad Genetics, Inc., Q4 2023 Earnings Call, Feb 27, 2024 |
Financials (USD)
Sales 2024 * | 828M | Sales 2025 * | 897M | Capitalization | 1.63B |
---|---|---|---|---|---|
Net income 2024 * | -91M | Net income 2025 * | -64M | EV / Sales 2024 * | 1.94 x |
Net cash position 2024 * | 21.96M | Net Debt 2025 * | 10.91M | EV / Sales 2025 * | 1.83 x |
P/E ratio 2024 * |
-19.4
x | P/E ratio 2025 * |
-29
x | Employees | 2,700 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.65% |
Latest transcript on Myriad Genetics, Inc.
1 day | -3.49% | ||
1 week | -2.86% | ||
Current month | -15.67% | ||
1 month | -18.20% | ||
3 months | -18.64% | ||
6 months | +22.40% | ||
Current year | -6.06% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Diaz
CEO | Chief Executive Officer | 61 | 20-08-12 |
Scott Leffler
DFI | Director of Finance/CFO | 49 | Jan. 28 |
Dale Muzzey
CTO | Chief Tech/Sci/R&D Officer | 44 | 14-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
S. Phanstiel
CHM | Chairman | 65 | 09-09-15 |
Paul Bisaro
BRD | Director/Board Member | 63 | 22-10-30 |
Dan Spiegelman
BRD | Director/Board Member | 65 | 20-05-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.24% | 16 M€ | -8.49% | ||
0.26% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 18.26 | +1.56% | 54 623 |
24-04-25 | 17.98 | -3.49% | 582,160 |
24-04-24 | 18.63 | +0.16% | 481,133 |
24-04-23 | 18.6 | +0.59% | 508,160 |
24-04-22 | 18.49 | -0.05% | 485,015 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.06% | 1.63B | |
-0.30% | 12.59B | |
-12.53% | 7.42B | |
+1.74% | 5.35B | |
-1.37% | 4.51B | |
+5.16% | 4.47B | |
-51.93% | 3.21B | |
+11.34% | 2.71B | |
-18.18% | 1.96B | |
-11.07% | 1.73B |
- Stock Market
- Equities
- MYGN Stock